Submitted by Anonymous (not verified) on 16 May 2025 - 13:55
Human medicines European public assessment report (EPAR): Bortezomib Hospira, bortezomib, Date of authorisation: 22/07/2016, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bortezomib Hospira, bortezomib, Date of authorisation: 22/07/2016, Revision: 14, Status: Authorised